Tango Therapeutics, Inc. · NASDAQ:TNGX

Crystal Adam sold 5,000 Tango Therapeutics, Inc. shares (Form 4)

Traded Nov 2, 2026 · Filed Nov 4, 2026

On Nov 2, 2026, Crystal Adam (President, R&D) sold 5,000 Tango Therapeutics, Inc. shares at an average US$22.42 for US$112K under a trading plan, leaving 115,743 shares. Filed Nov 4, 2026 (Form 4).

Sold
5,000 shares
Price
US$22.42 average (US$22.26 to US$22.99)
Value
US$112K
Holding after
115,743 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President, R&D

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 2, 2026Common StockOption exercise5,000US$2.91120,743Direct
Nov 2, 2026Common StockSale3,900US$22.26116,843Direct
Nov 2, 2026Common StockSale1,100US$22.99115,743Direct

Source

Download original · View original at SEC

Related